Izotropic Corporation (IZO.CN) Research

Izotropic Corporation operates as a MedTech enterprise, concentrating on the commercialization of diagnostic solutions for breast cancer. Their primary focus lies in developing and offering a breast CT imaging system alongside a 3D CT breast imaging platform, both specifically designed to enable earlier detection and more accurate diagnosis of the disease. Established in 2016, the company maintains its corporate base in Surrey, Canada.

Market snapshot

Symbol
IZO.CN
Price
$0.25
Day change
0.00%
Market cap
$17.2M
P/E ratio
-6.35x
52-week range
0.19-0.49
Sector
Healthcare
Industry
Medical - Diagnostics & Research

Peer companies

  • DIAGNOS Inc. (ADK.V)
  • Avicanna Inc. (AVCN.TO)
  • BriaCell Therapeutics Corp. (BCT.TO)
  • BioMark Diagnostics Inc. (BUX.CN)
  • Charlotte's Web Holdings, Inc. (CWEB.TO)
  • Gemina Laboratories Ltd. (GLAB.CN)
  • MediPharm Labs Corp. (LABS.TO)
  • Perimeter Medical Imaging AI, Inc. (PINK.V)

Open Izotropic Corporation (IZO.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.